Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 303

Results For "Men"

10189 News Found

Incyte eyes first-line nod for Tafasitamab in aggressive lymphoma
News | January 07, 2026

Incyte eyes first-line nod for Tafasitamab in aggressive lymphoma

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma (NHL) in adults, represents 40% of all cases worldwide


MetaVia’s DA-1726 shows breakthrough weight loss in Phase 1 trial
Biotech | January 07, 2026

MetaVia’s DA-1726 shows breakthrough weight loss in Phase 1 trial

Fasting glucose improved by 12.3 mg/dL, while liver stiffness dropped 23.7%, signaling a direct hepatic benefit


Medera doses final patient in high-dose HFpEF gene therapy trial
Biopharma | January 07, 2026

Medera doses final patient in high-dose HFpEF gene therapy trial

Heart failure affects an estimated 64.3 million people worldwide


Kelun-Biotech secures IND nod for innovative cancer therapy SKB105 in China
Biopharma | January 07, 2026

Kelun-Biotech secures IND nod for innovative cancer therapy SKB105 in China

Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001


Merck completes acquisition of Cidara Therapeutics
News | January 07, 2026

Merck completes acquisition of Cidara Therapeutics

Cidara will become a wholly owned subsidiary of Merck and the common stock of Cidara will no longer be listed or traded on the Nasdaq Global Market


Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
Opinion | January 07, 2026

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader

India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry


PathoCare Holdings valued at $1.75 billion following major third-party tender offer
News | January 06, 2026

PathoCare Holdings valued at $1.75 billion following major third-party tender offer

The company previously completed a $150 million venture investment, acquisition, and recapitalization


Insilico Medicine teams up with Servier to fast-track AI-driven cancer drugs
R&D | January 06, 2026

Insilico Medicine teams up with Servier to fast-track AI-driven cancer drugs

Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments


Jubilant Ingrevia appoints Pravesh Kumar Garg as Chief of Manufacturing
People | January 06, 2026

Jubilant Ingrevia appoints Pravesh Kumar Garg as Chief of Manufacturing

Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence


Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
People | January 06, 2026

Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer

Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector